Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, Eto T (March 1998). "The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma". Biochem. Biophys. Res. Commun. 244 (2): 551–5. doi:10.1006/bbrc.1998.8310. PMID9514956.
Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shoukouji T, Nishiyama A, Kimura S, Abe Y (August 2004). "Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats". Eur. J. Pharmacol. 497 (1): 75–80. doi:10.1016/j.ejphar.2004.06.039. PMID15321737.
Hamid SA, Baxter GF (February 2005). "Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction". Pharmacol. Ther. 105 (2): 95–112. doi:10.1016/j.pharmthera.2004.08.012. PMID15670621.
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (May 1998). "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor". Nature. 393 (6683): 333–9. Bibcode:1998Natur.393..333M. doi:10.1038/30666. PMID9620797. S2CID4364526.
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (May 1998). "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor". Nature. 393 (6683): 333–9. Bibcode:1998Natur.393..333M. doi:10.1038/30666. PMID9620797. S2CID4364526.
nih.gov
pubmed.ncbi.nlm.nih.gov
Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, Eto T (March 1998). "The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma". Biochem. Biophys. Res. Commun. 244 (2): 551–5. doi:10.1006/bbrc.1998.8310. PMID9514956.
Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shoukouji T, Nishiyama A, Kimura S, Abe Y (August 2004). "Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats". Eur. J. Pharmacol. 497 (1): 75–80. doi:10.1016/j.ejphar.2004.06.039. PMID15321737.
Hamid SA, Baxter GF (February 2005). "Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction". Pharmacol. Ther. 105 (2): 95–112. doi:10.1016/j.pharmthera.2004.08.012. PMID15670621.
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (May 1998). "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor". Nature. 393 (6683): 333–9. Bibcode:1998Natur.393..333M. doi:10.1038/30666. PMID9620797. S2CID4364526.
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (May 1998). "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor". Nature. 393 (6683): 333–9. Bibcode:1998Natur.393..333M. doi:10.1038/30666. PMID9620797. S2CID4364526.